Autoimmune Peripheral Neuropathy: A New Paradigm Shift - Insights
axonal or demyelinating testing for peripheral neuropathy. This approach can help identify specific antibodies associated with the condition, providing a more precise diagnosis, and improving patient outcomes...
Autoimmune Neurology Testing - Insights
Autoimmune neurology is a rapidly evolving subspecialty driven by the discovery that the immune system can target virtually any structure within the
Novel biomarkers added to movement disorders profile - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.
New Tests - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
MCL Autoimmune Axonal Neuropathy A Comprehensive Testing Approach MC2775425
MCL Autoimmune Axonal Neuropathy Comprehensive Testing Approach NEUROLOGY AUTOIMMUNE AXONAL NEUROPATHY COMPREHENSIVE TESTING APPROACH Patients neuropathy variable sensory motor disturbance loss exaggerated
Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.
Myasthenia Gravis Testing - Mayo Clinic Laboratories
Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.
Mayo Clinic Laboratory and pathology research roundup: November 16 - Insights
This week’s research roundup features: Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology.
Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...